Digwal
Our Digwal, India facility is a USFDA, UK MHRA, PMDA JAPAN and ANVISA inspected site that offers development and commercial GMP manufacturing of Active Pharmaceutical Ingredients (APIs) / key intermediates. Site is equipped with R&D lab, pilot plant, commercial blocks, quality control lab, utility system and centralized Zero Liquid Discharge plant.
Piramal Pharma Limited, Digwal Village, Kohir Mandal, Sangareddy District, Telangana 502321, India
Specialized Capabilities
- cGMP facility supplying APIs to global markets since 2002
- Multi-purpose upgraded kilo lab facility and pilot plant (5-50 kgs) with ANFD, powder transfer system, and hydrogenation
- Dedicated and multi-purpose units with reactor volumes ranging from 250 L to 8 KL for API
- Variety of chemical reactions including bromination, hydrogenation, and alkylation
- Customized particle size requirements
- API regulatory submissions across the globe including e-CTD
Salient Features
- Three Independent manufacturing units with multi-purpose plants for production of low and high-volume APIs
- Clean environment without penicillin, cephalosporin, and steroids production
- Process development laboratory for process familiarization
- Systemic technology transfer from lab scale to plant scale
- Capability to file DMF for customers globally